User menu

Randomised, placebo-controlled, double-blind, parallel-group phase III study evaluating aflibercept in patients receiving first-line treatment with gemcitabine for metastatic pancreatic cancer.

Bibliographic reference Rougier, Philippe ; Riess, Hanno ; Manges, Robert ; Karasek, Petr ; Humblet, Yves ; et. al. Randomised, placebo-controlled, double-blind, parallel-group phase III study evaluating aflibercept in patients receiving first-line treatment with gemcitabine for metastatic pancreatic cancer.. In: European Journal of Cancer, Vol. 49, no.12, p. 2633-2642 (2013)
Permanent URL http://hdl.handle.net/2078.1/156808